Global Neurostimulation Devices Market: By Product Type (Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Spinal Cord Stimulators (SCS), Sacral Nerve Stimulators (SNS), and Vagus Nerve Stimulators (VNS)), By Application (Management of Pain, Parkinson’s Disease, Epilepsy, Gastroparesis, Tremors, Urinary & Fecal Incontinence, Depression, Dystonia, and Others) By Device Type (Invasive Devices and Non-Invasive Devices) By End User (Hospitals, Ambulatory Surgical Centers, and Neuro Clinics), and Geography: – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Market for Neurostimulation devices was valued around US$ 3.7 bn in 2015 and projected to expand around 8% CAGR over 2017 to 2023
Market Introduction: Neurostimulation Devices Market
Neurostimulation is the process of modulating the nervous system by means of neurostimulation devices to improve quality of life (QOL) patients suffering from epilepsy, pain, depression, parkinsonism etc., Neurostimulation devices work by intervening the body’s nervous system by effecting the nerve signal conduction.
Market Dynamics: Neurostimulation Devices Market
Increasing demand for minimally invasive devices coupled with availability of technologically advanced products expected to propel the market revenue for Neurostimulation devices over the forecast period. Apart from above drivers, market for neuromodulation devices affected by rising aging population across the globe, growing interest of healthcare professionals for alternative treatment and ability of the neurostimulation devices to provide safe and effective treatments alternative for the patients who are resistant to therapeutic options is driving the market revenue in positive traction. However, higher cost of neuromodulation in developing economies, cumbersome regulatory processes expected to impede the market revenue growth of over the forecast period.
Market Segmentation: Neurostimulation Devices Market
Neurostimulation Devices Market has been segmented on the basis of product type, application, and end user
Based on the product type, Neurostimulation devices market has been segmented into the following:
Neurostimulation devices market is oligopolistic in nature, where larger market revenue is with top four players in Neurostimulation devices market. Smaller and emerging players in the market developing cutting edge innovations and becoming the target for merger and acquisitions by top players in the Neurostimulation devices market. Development of newer technologies and expanded applications for the neurostimulation devices expected to fuel market demand for the devices over forecast period. For instance in 2014, Medtronic plc acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep brain stimulation (DBS) technologies, Sapiens Steering developed SureStim-1System that helps in averting side effects stems for stimulating the non-target area.
Region Overview: Neurostimulation Devices Market
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and Europe markets accounted for a major market revenue share of Neurostimulation devices market and projected to hold larger market share over the forecast period. Favourable reimbursement policies for neurostimulation devices like new category 1 CPT code for Percutaneous Tibial Nerve Stimulation (PTNS) in U.S. and product approvals in Europe (CE Mark) for EndoStim’s LES Stimulation System etc. expected to drive the market. Market for Neurostimulation devices in Asia Pacific region forecasted to grow at significant growth rate owing to increased localized development of the neurostimulation devices. For instance in china based Jingyu Medical Device independently developed Deep Brain Stimulation (DBS) device in 2015. Apart from that, large patient pool, and improving healthcare infrastructure in the region expected to drive the market.
Market Participants: Neurostimulation Devices Market
Global Neurostimulation devices market dominated by key players such as Boston Scientific, Cyberonics, Medtronic and St. Jude Medical, and Nevro Corporation to name a few. Market players majorly focused on developing newer technologies, new product introductions, and geographical expansion to cater larger market. For instance, in 2016, St. Jude medical unveiled Deep Brain Stimulator (DBS) in Europe market to treat patients suffering from Dystonia, Parkinson’s disease, and tremor.
Key Market Developments: Neurostimulation Devices Market
Market Introduction: Neurostimulation Devices Market
Neurostimulation is the process of modulating the nervous system by means of neurostimulation devices to improve quality of life (QOL) patients suffering from epilepsy, pain, depression, parkinsonism etc., Neurostimulation devices work by intervening the body’s nervous system by effecting the nerve signal conduction.
Market Dynamics: Neurostimulation Devices Market
Increasing demand for minimally invasive devices coupled with availability of technologically advanced products expected to propel the market revenue for Neurostimulation devices over the forecast period. Apart from above drivers, market for neuromodulation devices affected by rising aging population across the globe, growing interest of healthcare professionals for alternative treatment and ability of the neurostimulation devices to provide safe and effective treatments alternative for the patients who are resistant to therapeutic options is driving the market revenue in positive traction. However, higher cost of neuromodulation in developing economies, cumbersome regulatory processes expected to impede the market revenue growth of over the forecast period.
Market Segmentation: Neurostimulation Devices Market
Neurostimulation Devices Market has been segmented on the basis of product type, application, and end user
Based on the product type, Neurostimulation devices market has been segmented into the following:
- Deep Brain Stimulators (DBS)
- Gastric Electric Stimulators (GES)
- Spinal Cord Stimulators (SCS)
- Sacral Nerve Stimulators (SNS)
- Vagus Nerve Stimulators (VNS)
- Management of Pain
- Parkinson’s Disease
- Epilepsy
- Gastroparesis
- Tremors
- Urinary & Fecal Incontinence
- Depression
- Dystonia
- Others
- Invasive Devices
- Non-Invasive Devices
- Hospitals
- Ambulatory Surgical Centers
- Neuro Clinics
Neurostimulation devices market is oligopolistic in nature, where larger market revenue is with top four players in Neurostimulation devices market. Smaller and emerging players in the market developing cutting edge innovations and becoming the target for merger and acquisitions by top players in the Neurostimulation devices market. Development of newer technologies and expanded applications for the neurostimulation devices expected to fuel market demand for the devices over forecast period. For instance in 2014, Medtronic plc acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep brain stimulation (DBS) technologies, Sapiens Steering developed SureStim-1System that helps in averting side effects stems for stimulating the non-target area.
Region Overview: Neurostimulation Devices Market
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and Europe markets accounted for a major market revenue share of Neurostimulation devices market and projected to hold larger market share over the forecast period. Favourable reimbursement policies for neurostimulation devices like new category 1 CPT code for Percutaneous Tibial Nerve Stimulation (PTNS) in U.S. and product approvals in Europe (CE Mark) for EndoStim’s LES Stimulation System etc. expected to drive the market. Market for Neurostimulation devices in Asia Pacific region forecasted to grow at significant growth rate owing to increased localized development of the neurostimulation devices. For instance in china based Jingyu Medical Device independently developed Deep Brain Stimulation (DBS) device in 2015. Apart from that, large patient pool, and improving healthcare infrastructure in the region expected to drive the market.
Market Participants: Neurostimulation Devices Market
Global Neurostimulation devices market dominated by key players such as Boston Scientific, Cyberonics, Medtronic and St. Jude Medical, and Nevro Corporation to name a few. Market players majorly focused on developing newer technologies, new product introductions, and geographical expansion to cater larger market. For instance, in 2016, St. Jude medical unveiled Deep Brain Stimulator (DBS) in Europe market to treat patients suffering from Dystonia, Parkinson’s disease, and tremor.
Key Market Developments: Neurostimulation Devices Market
- Development of closed loop – modulation technologies is major technological breakthrough in neurostimulation devices market.
- In 2016, Medtronic plc got regulatory clearance for world first complete portfolio of full-body MR conditional neurotransmitter system for chronic pain.
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL NEUROSTIMULATION DEVICES MARKET INTRODUCTION
2.1. Global Neurostimulation Devices Market – Taxonomy
2.2. Global Neurostimulation Devices Market–Definitions
2.2.1. Application
2.2.2. Product Type
2.2.3. Device Type
2.2.4. End User
2.2.5. Region
3. GLOBAL NEUROSTIMULATION DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Neurostimulation Devices Market Dynamics – Factors Impact Analysis
3.6. Global Neurostimulation Devices Market Dynamics – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Neurostimulation Devices Market– Product Innovations
4. GLOBAL NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 – 2025
4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2017 - 2023
5.1. Management of Pain
5.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Parkinson’s Disease
5.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Epilepsy
5.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Gastroparesis
5.4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Tremors
5.5.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Urinary & Fecal Incontinence
5.6.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
5.7. Depression
5.7.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.7.3. Market Opportunity Analysis
5.8. Dystonia
5.8.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.8.3. Market Opportunity Analysis
6. GLOBAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2017 - 2023
6.1. Deep Brain Stimulators (DBS)
6.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.2. Gastric Electric Stimulators (GES)
6.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Spinal Cord Stimulators (SCS)
6.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.4. Sacral Nerve Stimulators (SNS)
6.4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.5. Vagus Nerve Stimulators (VNS)
6.5.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.5.3. Market Opportunity Analysis
7. GLOBAL NEUROSTIMULATION DEVICES MARKET FORECAST, BY DEVICE TYPE, 2017 - 2023
7.1. Invasive Devices
7.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Non-Invasive Devices
7.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
8. GLOBAL NEUROSTIMULATION DEVICES MARKET FORECAST, BY END USER, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Ambulatory Surgical Centers
8.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Neuro Clinics
8.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
9. GLOBAL NEUROSTIMULATION DEVICES MARKET FORECAST, BY REGION, 2017 - 2023
9.1. North America
9.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East & Africa
9.5.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User and Region, 2017 – 2025
10. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
10.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Management of Pain
10.1.1.2. Parkinson’s Disease
10.1.1.3. Epilepsy
10.1.1.4. Gastroparesis
10.1.1.5. Tremors
10.1.1.6. Urinary & Fecal Incontinence
10.1.1.7. Depression
10.1.1.8. Dystonia
10.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.2.1. Deep Brain Stimulators (DBS)
10.1.2.2. Gastric Electric Stimulators (GES)
10.1.2.3. Spinal Cord Stimulators (SCS)
10.1.2.4. Sacral Nerve Stimulators (SNS)
10.1.2.5. Vagus Nerve Stimulators (VNS)
10.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.3.1. Invasive Devices
10.1.3.2. Non-Invasive Devices
10.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Ambulatory Surgical Centers
10.1.4.3. Neuro Clinics
10.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.5.1. U.S
10.1.5.2. Canada
10.1.6. North America Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User, and Country, 2017 – 2025
10.1.7. North America Neurostimulation Devices Market Dynamics - Trends
11. EUROPE NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
11.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Management of Pain
11.1.1.2. Parkinson’s Disease
11.1.1.3. Epilepsy
11.1.1.4. Gastroparesis
11.1.1.5. Tremors
11.1.1.6. Urinary & Fecal Incontinence
11.1.1.7. Depression
11.1.1.9. Dystonia
11.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.2 Deep Brain Stimulators (DBS)
11.1.2.1. Gastric Electric Stimulators (GES)
11.1.2.2. Spinal Cord Stimulators (SCS)
11.1.2.3. Sacral Nerve Stimulators (SNS)
11.1.2.4. Vagus Nerve Stimulators (VNS)
11.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.3.1. Invasive Devices
11.1.3.2. Non-Invasive Devices
11.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Ambulatory Surgical Centers
11.1.4.3. Neuro Clinics
11.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Italy
11.1.5.5. Spain
11.1.5.6. Poland 11.1.5.7. Russia
11.1.5.8. Rest of Europe
11.1.6. Europe Neurostimulation Devices Market - Opportunity Analysis Index, By Application, Product Type, Device Type, End User, and Country, 2017 – 2025
11.1.7. Europe Neurostimulation Devices Market Dynamics - Trends
12. ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
12.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Management of Pain
12.1.1.2. Parkinson’s Disease
12.1.1.3. Epilepsy
12.1.1.4. Gastroparesis
12.1.1.5. Tremors
12.1.1.6. Urinary & Fecal Incontinence
12.1.1.7. Depression
12.1.1.9. Dystonia
12.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.2.1. Deep Brain Stimulators (DBS)
12.1.2.2. Gastric Electric Stimulators (GES)
12.1.2.3. Spinal Cord Stimulators (SCS)
12.1.2.4. Sacral Nerve Stimulators (SNS)
12.1.2.5. Vagus Nerve Stimulators (VNS)
12.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.3.1. Invasive Devices
12.1.3.2. Non-Invasive Devices
12.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Ambulatory Surgical Centers
12.1.4.3. Neuro Clinics
12.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand 12.1.5.6. Rest of APAC
12.1.6. Asia-Pacific Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User, and Country, 2017 – 2025
12.1.7. Asia-Pacific Neurostimulation Devices Market Dynamics - Trends
13. LATIN AMERICA NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
13.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Management of Pain
13.1.1.2. Parkinson’s Disease
13.1.1.3. Epilepsy
13.1.1.4. Gastroparesis
13.1.1.5. Tremors
13.1.1.6. Urinary & Fecal Incontinence
13.1.1.7. Depression
13.1.1.9. Dystonia
13.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.2.1. Deep Brain Stimulators (DBS)
13.1.2.2. Gastric Electric Stimulators (GES)
13.1.2.3. Spinal Cord Stimulators (SCS)
13.1.2.4. Sacral Nerve Stimulators (SNS)
13.1.2.5. Vagus Nerve Stimulators (VNS)
13.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.3.1. Invasive Devices
13.1.3.2. Non-Invasive Devices
13.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Ambulatory Surgical Centers
13.1.4.3. Neuro Clinics
13.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User, and Country, 2017 – 2025
13.1.7. Latin America Neurostimulation Devices Market Dynamics - Trends
14. MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
14.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Management of Pain
14.1.1.2. Parkinson’s Disease
14.1.1.3. Epilepsy
14.1.1.4. Gastroparesis
14.1.1.5. Tremors
14.1.1.6. Urinary & Fecal Incontinence
14.1.1.7. Depression
14.1.1.9. Dystonia
14.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.2.1. Deep Brain Stimulators (DBS)
14.1.2.2. Gastric Electric Stimulators (GES)
14.1.2.3. Spinal Cord Stimulators (SCS)
14.1.2.4. Sacral Nerve Stimulators (SNS)
14.1.2.5. Vagus Nerve Stimulators (VNS)
14.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.3.1. Invasive Devices
14.1.3.2. Non-Invasive Devices
14.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Ambulatory Surgical Centers
14.1.4.3. Neuro Clinics
14.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. Middle East & Africa Neurostimulation Devices Market - Opportunity Analysis Index, By Application, Product Type, Device Type, End User, and Country, 2017 – 2025
14.1.7. Middle East & Africa Dynamics - Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Boston Scientific
15.2.2. Cyberonics
15.2.3. Medtronic
15.2.4. St. Jude Medical
15.2.5. Nevro Corporation
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND AC
2. GLOBAL NEUROSTIMULATION DEVICES MARKET INTRODUCTION
2.1. Global Neurostimulation Devices Market – Taxonomy
2.2. Global Neurostimulation Devices Market–Definitions
2.2.1. Application
2.2.2. Product Type
2.2.3. Device Type
2.2.4. End User
2.2.5. Region
3. GLOBAL NEUROSTIMULATION DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Neurostimulation Devices Market Dynamics – Factors Impact Analysis
3.6. Global Neurostimulation Devices Market Dynamics – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Neurostimulation Devices Market– Product Innovations
4. GLOBAL NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 – 2025
4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2017 - 2023
5.1. Management of Pain
5.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Parkinson’s Disease
5.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Epilepsy
5.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Gastroparesis
5.4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Tremors
5.5.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Urinary & Fecal Incontinence
5.6.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
5.7. Depression
5.7.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.7.3. Market Opportunity Analysis
5.8. Dystonia
5.8.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.8.3. Market Opportunity Analysis
6. GLOBAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2017 - 2023
6.1. Deep Brain Stimulators (DBS)
6.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.2. Gastric Electric Stimulators (GES)
6.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Spinal Cord Stimulators (SCS)
6.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.4. Sacral Nerve Stimulators (SNS)
6.4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.5. Vagus Nerve Stimulators (VNS)
6.5.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.5.3. Market Opportunity Analysis
7. GLOBAL NEUROSTIMULATION DEVICES MARKET FORECAST, BY DEVICE TYPE, 2017 - 2023
7.1. Invasive Devices
7.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Non-Invasive Devices
7.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
8. GLOBAL NEUROSTIMULATION DEVICES MARKET FORECAST, BY END USER, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Ambulatory Surgical Centers
8.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Neuro Clinics
8.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
9. GLOBAL NEUROSTIMULATION DEVICES MARKET FORECAST, BY REGION, 2017 - 2023
9.1. North America
9.1.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East & Africa
9.5.1. Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User and Region, 2017 – 2025
10. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
10.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Management of Pain
10.1.1.2. Parkinson’s Disease
10.1.1.3. Epilepsy
10.1.1.4. Gastroparesis
10.1.1.5. Tremors
10.1.1.6. Urinary & Fecal Incontinence
10.1.1.7. Depression
10.1.1.8. Dystonia
10.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.2.1. Deep Brain Stimulators (DBS)
10.1.2.2. Gastric Electric Stimulators (GES)
10.1.2.3. Spinal Cord Stimulators (SCS)
10.1.2.4. Sacral Nerve Stimulators (SNS)
10.1.2.5. Vagus Nerve Stimulators (VNS)
10.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.3.1. Invasive Devices
10.1.3.2. Non-Invasive Devices
10.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Ambulatory Surgical Centers
10.1.4.3. Neuro Clinics
10.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.5.1. U.S
10.1.5.2. Canada
10.1.6. North America Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User, and Country, 2017 – 2025
10.1.7. North America Neurostimulation Devices Market Dynamics - Trends
11. EUROPE NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
11.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Management of Pain
11.1.1.2. Parkinson’s Disease
11.1.1.3. Epilepsy
11.1.1.4. Gastroparesis
11.1.1.5. Tremors
11.1.1.6. Urinary & Fecal Incontinence
11.1.1.7. Depression
11.1.1.9. Dystonia
11.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.2 Deep Brain Stimulators (DBS)
11.1.2.1. Gastric Electric Stimulators (GES)
11.1.2.2. Spinal Cord Stimulators (SCS)
11.1.2.3. Sacral Nerve Stimulators (SNS)
11.1.2.4. Vagus Nerve Stimulators (VNS)
11.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.3.1. Invasive Devices
11.1.3.2. Non-Invasive Devices
11.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Ambulatory Surgical Centers
11.1.4.3. Neuro Clinics
11.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Italy
11.1.5.5. Spain
11.1.5.6. Poland 11.1.5.7. Russia
11.1.5.8. Rest of Europe
11.1.6. Europe Neurostimulation Devices Market - Opportunity Analysis Index, By Application, Product Type, Device Type, End User, and Country, 2017 – 2025
11.1.7. Europe Neurostimulation Devices Market Dynamics - Trends
12. ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
12.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Management of Pain
12.1.1.2. Parkinson’s Disease
12.1.1.3. Epilepsy
12.1.1.4. Gastroparesis
12.1.1.5. Tremors
12.1.1.6. Urinary & Fecal Incontinence
12.1.1.7. Depression
12.1.1.9. Dystonia
12.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.2.1. Deep Brain Stimulators (DBS)
12.1.2.2. Gastric Electric Stimulators (GES)
12.1.2.3. Spinal Cord Stimulators (SCS)
12.1.2.4. Sacral Nerve Stimulators (SNS)
12.1.2.5. Vagus Nerve Stimulators (VNS)
12.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.3.1. Invasive Devices
12.1.3.2. Non-Invasive Devices
12.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Ambulatory Surgical Centers
12.1.4.3. Neuro Clinics
12.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand 12.1.5.6. Rest of APAC
12.1.6. Asia-Pacific Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User, and Country, 2017 – 2025
12.1.7. Asia-Pacific Neurostimulation Devices Market Dynamics - Trends
13. LATIN AMERICA NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
13.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Management of Pain
13.1.1.2. Parkinson’s Disease
13.1.1.3. Epilepsy
13.1.1.4. Gastroparesis
13.1.1.5. Tremors
13.1.1.6. Urinary & Fecal Incontinence
13.1.1.7. Depression
13.1.1.9. Dystonia
13.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.2.1. Deep Brain Stimulators (DBS)
13.1.2.2. Gastric Electric Stimulators (GES)
13.1.2.3. Spinal Cord Stimulators (SCS)
13.1.2.4. Sacral Nerve Stimulators (SNS)
13.1.2.5. Vagus Nerve Stimulators (VNS)
13.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.3.1. Invasive Devices
13.1.3.2. Non-Invasive Devices
13.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Ambulatory Surgical Centers
13.1.4.3. Neuro Clinics
13.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Neurostimulation Devices Market - Opportunity Analysis Index, By
Application, Product Type, Device Type, End User, and Country, 2017 – 2025
13.1.7. Latin America Neurostimulation Devices Market Dynamics - Trends
14. MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICES MARKET ANALYSIS 2017 - 2023
14.1.1. Application Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Management of Pain
14.1.1.2. Parkinson’s Disease
14.1.1.3. Epilepsy
14.1.1.4. Gastroparesis
14.1.1.5. Tremors
14.1.1.6. Urinary & Fecal Incontinence
14.1.1.7. Depression
14.1.1.9. Dystonia
14.1.2. Product Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.2.1. Deep Brain Stimulators (DBS)
14.1.2.2. Gastric Electric Stimulators (GES)
14.1.2.3. Spinal Cord Stimulators (SCS)
14.1.2.4. Sacral Nerve Stimulators (SNS)
14.1.2.5. Vagus Nerve Stimulators (VNS)
14.1.3. Device Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.3.1. Invasive Devices
14.1.3.2. Non-Invasive Devices
14.1.4. End User Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Ambulatory Surgical Centers
14.1.4.3. Neuro Clinics
14.1.5. Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. Middle East & Africa Neurostimulation Devices Market - Opportunity Analysis Index, By Application, Product Type, Device Type, End User, and Country, 2017 – 2025
14.1.7. Middle East & Africa Dynamics - Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Boston Scientific
15.2.2. Cyberonics
15.2.3. Medtronic
15.2.4. St. Jude Medical
15.2.5. Nevro Corporation
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND AC
